Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 13.5% in January

Venus Concept Inc. (NASDAQ:VERO) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totaling 172,610 shares, a decrease of 13.5% from the December 31st total of 199,499 shares. Based on an average daily volume of 1,896,828 shares, the days-to-cover ratio is presently 0.1 days. Currently, 16.8% of the shares of the stock are short sold. Currently, 16.8% of the shares of the stock are short sold. Based on an average daily volume of 1,896,828 shares, the days-to-cover ratio is presently 0.1 days.

Venus Concept Stock Down 9.3%

NASDAQ:VERO opened at $1.27 on Wednesday. The company has a quick ratio of 0.59, a current ratio of 0.90 and a debt-to-equity ratio of 1.59. The stock’s 50 day moving average price is $1.99 and its two-hundred day moving average price is $2.18. Venus Concept has a twelve month low of $1.16 and a twelve month high of $14.50. The firm has a market capitalization of $1.80 million, a price-to-earnings ratio of -0.03 and a beta of -0.01.

Venus Concept (NASDAQ:VERO) last released its quarterly earnings data on Thursday, November 13th. The company reported ($12.14) earnings per share for the quarter, missing the consensus estimate of ($3.61) by ($8.53). Venus Concept had a negative return on equity of 1,904.25% and a negative net margin of 92.76%.The firm had revenue of $13.78 million for the quarter, compared to analyst estimates of $14.48 million.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Venus Concept in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Venus Concept Company Profile

Venus Concept Ltd. (NASDAQ: VERO) is a Canada-based medical aesthetic device company that designs, develops and commercializes minimally and noninvasive solutions for face and body rejuvenation. The company’s core product portfolio leverages proprietary technologies such as multi-polar radio frequency, pulsed electromagnetic fields and intense pulsed light to offer treatments for skin tightening, body contouring, wrinkle reduction and vascular lesion removal.

Among its flagship offerings are the Venus Legacy platform, which combines radio frequency and electromagnetic pulses for cellulite reduction and circumferential reduction, and the Venus Versa system, a multi-application device for facial revitalization, acne treatment, hair removal and photorejuvenation.